The best + ICD trial

R. Cappato; M. G. Bongiorni; M. Brignole; A. Capucci; F. Gaita; S. Mangiameli; A. Montenero; R. Pedretti; A. Raviele; J. Salerno; S. Sermasi

The best + ICD trial

R. Cappato, M. G. Bongiorni, M. Brignole, A. Capucci, F. Gaita, S. Mangiameli, A. Montenero, R. Pedretti, A. Raviele, J. Salerno, S. Sermasi

Research output: Contribution to journal › Article › peer-review

Abstract

The BEta-blocker STrategy plus Implantable Cardioverter Defibrillator (BEST + ICD) Trial is a multicenter prospective randomized study in which the hypothesis will be tested of whether, in high-risk post-myocardial infarction (MI) patients already treated with β-blockers, therapy guided by electrophysiologic study (EPS) will improve survival, compared to conventional therapy. Eligible patients for the study are survivors of a recent MI (>5 and

Original language	English
Pages (from-to)	15-22
Number of pages	8
Journal	Herzschrittmachertherapie und Elektrophysiologie
Volume	10
Issue number	SUPPL. 2
Publication status	Published - 1999

Keywords

Defibrillator
Implantable cardioverter
Primary prevention
Prophylactic implantation

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Cite this

@article{131ee33e3c7e4995a90c99e5f020abb1,

title = "The best + ICD trial",

abstract = "The BEta-blocker STrategy plus Implantable Cardioverter Defibrillator (BEST + ICD) Trial is a multicenter prospective randomized study in which the hypothesis will be tested of whether, in high-risk post-myocardial infarction (MI) patients already treated with β-blockers, therapy guided by electrophysiologic study (EPS) will improve survival, compared to conventional therapy. Eligible patients for the study are survivors of a recent MI (>5 and ",

keywords = "Defibrillator, Implantable cardioverter, Primary prevention, Prophylactic implantation",

author = "R. Cappato and Bongiorni, {M. G.} and M. Brignole and A. Capucci and F. Gaita and S. Mangiameli and A. Montenero and R. Pedretti and A. Raviele and J. Salerno and S. Sermasi",

year = "1999",

language = "English",

volume = "10",

pages = "15--22",

journal = "Herzschrittmachertherapie und Elektrophysiologie",

issn = "0938-7412",

publisher = "D. Steinkopff-Verlag",

number = "SUPPL. 2",

}

TY - JOUR

T1 - The best + ICD trial

AU - Cappato, R.

AU - Bongiorni, M. G.

AU - Brignole, M.

AU - Capucci, A.

AU - Gaita, F.

AU - Mangiameli, S.

AU - Montenero, A.

AU - Pedretti, R.

AU - Raviele, A.

AU - Salerno, J.

AU - Sermasi, S.

PY - 1999

Y1 - 1999

N2 - The BEta-blocker STrategy plus Implantable Cardioverter Defibrillator (BEST + ICD) Trial is a multicenter prospective randomized study in which the hypothesis will be tested of whether, in high-risk post-myocardial infarction (MI) patients already treated with β-blockers, therapy guided by electrophysiologic study (EPS) will improve survival, compared to conventional therapy. Eligible patients for the study are survivors of a recent MI (>5 and

AB - The BEta-blocker STrategy plus Implantable Cardioverter Defibrillator (BEST + ICD) Trial is a multicenter prospective randomized study in which the hypothesis will be tested of whether, in high-risk post-myocardial infarction (MI) patients already treated with β-blockers, therapy guided by electrophysiologic study (EPS) will improve survival, compared to conventional therapy. Eligible patients for the study are survivors of a recent MI (>5 and

KW - Defibrillator

KW - Implantable cardioverter

KW - Primary prevention

KW - Prophylactic implantation

UR - http://www.scopus.com/inward/record.url?scp=0032738593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032738593&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032738593

VL - 10

SP - 15

EP - 22

JO - Herzschrittmachertherapie und Elektrophysiologie

JF - Herzschrittmachertherapie und Elektrophysiologie

SN - 0938-7412

IS - SUPPL. 2

ER -

The best + ICD trial

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this